KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Treasury Shares (2019 - 2025)

Elanco Animal Health's Treasury Shares history spans 7 years, with the latest figure at $2.6 million for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 4.0% to $2.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.6 million, a 4.0% increase, with the full-year FY2025 number at $2.6 million, up 4.0% from a year prior.
  • Treasury Shares hit $2.6 million in Q4 2025 for Elanco Animal Health, up from $2.5 million in the prior quarter.
  • Over the last five years, Treasury Shares for ELAN hit a ceiling of $3.9 million in Q4 2023 and a floor of $1.0 million in Q4 2021.
  • Historically, Treasury Shares has averaged $2.4 million across 5 years, with a median of $2.5 million in 2024.
  • Biggest five-year swings in Treasury Shares: skyrocketed 100.0% in 2022 and later crashed 35.9% in 2024.
  • Tracing ELAN's Treasury Shares over 5 years: stood at $1.0 million in 2021, then skyrocketed by 100.0% to $2.0 million in 2022, then soared by 95.0% to $3.9 million in 2023, then tumbled by 35.9% to $2.5 million in 2024, then grew by 4.0% to $2.6 million in 2025.
  • Business Quant data shows Treasury Shares for ELAN at $2.6 million in Q4 2025, $2.5 million in Q4 2024, and $3.9 million in Q4 2023.